|
Marín F, Roldán V. Oral anticoagulation and comorbidities; too many details for clinical practice? Int J Cardiol. 2018 Aug 1;264:93-94. doi: 10.1016/j.ijcard.2018.03.115. PubMed PMID: 29776577.
AÑO: 2018; IF: 3.471
|
29776577
|
Roldán V, Marín F. Optimizing Vitamin K Antagonist Treatment in Patients with Mechanical Heart Valve Prosthesis. Thromb Haemost. 2018 May;118(5):806-807. doi: 10.1055/s-0038-1641737. Epub 2018 Apr 6. PubMed PMID: 29625499.
AÑO: 2018; IF: 6.681
|
|
Roldán V, Rivera-Caravaca JM, Shantsila A, García-Fernández A, Esteve-Pastor MA, Vilchez JA, Romera M, Valdés M, Vicente V, Marín F, Lip GYH. Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA(2)DS(2)-VASc and HAS-BLED scores using multiple biomarkers. Ann Med. 2018 Feb;50(1):26-34. doi: 10.1080/07853890.2017.1378429. Epub 2017 Sep 18. PubMed PMID: 28892413.
AÑO: 2018; IF: 3.049
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Vicente V, Romiti GF, Romanazzi I, Proietti M, Valdés M, Marín F, Lip GYH. Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients. Int J Cardiol. 2018 Mar 1;254:125-131. doi: 10.1016/j.ijcard.2017.11.087. Epub 2017 Dec 14. PubMed PMID: 29248163.
AÑO: 2018; IF: 3.471
|
|
Pastori D, Rivera-Caravaca JM, Esteve-Pastor MA, Roldán V, Marín F, Pignatelli P, Violi F, Lip GYH. Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. Circ J. 2018 Apr 25;82(5):1286-1292. doi: 10.1253/circj.CJ-17-1318. Epub 2018 Mar 16. PubMed PMID: 29553090.
AÑO: 2018; IF: 3.025
|